An Open Label, Single-arm Clinical Study Evaluating the Safety and Efficacy of ICI201 Infusion in Relapsed/Refractory Multiple Myeloma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
An open label, single-arm clinical study evaluating the safety and efficacy of ICI201 infusion in relapsed/refractory multiple myeloma
Epistemonikos ID: da7a7710e3d0010f10a039594419b3d6fbf1ce75
First added on: May 15, 2024